EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy

Yael Hoffman, Alina Kurolap, Hila Ledermann Nahmias, Adi Mory, Tal Freund, Avraham Unterman, Uri Hamiel, Hagit Baris Feldman, Daphna Marom, David Hagin

Journal of Clinical Immunology · 2026

DOI: 10.1007/s10875-026-02045-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Immunology, 2026. Verfasst von Yael Hoffman und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Genetics Institute and Genomics Center, Tel Aviv Sourasky University Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel. Hauptthemen laut MEDLINE: Killer Cells, Natural, Minichromosome Maintenance Proteins, Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Defects in components of the CDC45–MCM2-7–GINS (CMG) helicase complex have been associated with natural killer (NK) cell deficiency in rare inborn errors of immunity. Pathogenic biallelic variants in MCM10 have been reported in a limited number of individuals with severe immunologic and developmental phenotypes. We aimed to further delineate the clinical and immunologic spectrum of MCM10 deficiency.

Methods

Singleton exome sequencing, RNA splicing analysis, flow cytometry–based immunophenotyping, telomere length assessment, radiation sensitivity testing, and in silico analysis of publicly available single-cell RNA sequencing datasets were performed.

Results

A six-year-old boy presented with poikiloderma, photosensitivity, growth failure, and immune dysregulation. Exome sequencing identified a homozygous canonical splice-site variant in MCM10 (c.930 + 2T > A), resulting in an in-frame deletion of 17 amino acids within the oligonucleotide/oligosaccharide-binding (OB)-fold domain, confirmed at the RNA level.Immunophenotyping showed near-absent NK cells with increased NK-T cells and terminally differentiated CD8 T cells. While karyotype, telomere length, and radiation sensitivity were normal, limited MCM10 expression in replicating NK cells is suspected. During follow-up, the patient developed an aggressive Epstein–Barr virus–positive squamous cell carcinoma of the tongue, an exceedingly rare childhood malignancy.

Conclusion

This case expands the phenotypic spectrum of MCM10 -related inborn errors of immunity and supports a critical role for MCM10 in NK-cell development and immune homeostasis. The occurrence of a virus-associated malignancy suggests susceptibility and impaired immune surveillance. Together with previously described defects in CMG-complex components, these findings are consistent with an emerging group of DNA replication–associated immune disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalMinichromosome Maintenance ProteinsEpstein-Barr Virus InfectionsHerpesvirus 4, HumanRothmund-Thomson SyndromeHumansMaleChildImmunophenotypingExome SequencingAllelesMutationPhenotype

Stichwörter der Autor:innen

Inborn errors of immunity (IEI)MCM10MinichromosomopathyNK-cell deficiency (NKD)Primary immunodeficiency disorders (PIDD)

Substanzen

Minichromosome Maintenance ProteinsMCM10 protein, human

Autor:innen und Institutionen

  • The Genetics Institute and Genomics Center, Tel Aviv Sourasky University Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky University Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel.
  • Institute of Pulmonary Medicine, Center of Excellence for Interstitial Lung Diseases, Tel Aviv Sourasky University Medical Center, Tel Aviv, Israel.
  • The Genetics Institute and Genomics Center, Tel Aviv Sourasky University Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel. Daphnam@tlvmc.gov.il.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Daphnam@tlvmc.gov.il.

Förderung

  • Tel Aviv University

Zitieren

APA

Hoffman, Y., Kurolap, A., Ledermann Nahmias, H., Mory, A., Freund, T., Unterman, A., Hamiel, U., Baris Feldman, H., Marom, D., & Hagin, D. (2026). Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-026-02045-7

Vancouver

Hoffman Y, Kurolap A, Ledermann Nahmias H, Mory A, Freund T, Unterman A, et al. Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy. Journal of Clinical Immunology. 2026. doi:10.1007/s10875-026-02045-7

BibTeX
@article{Hoffman2026,
  author = {Hoffman, Yael and Kurolap, Alina and Ledermann Nahmias, Hila and Mory, Adi and Freund, Tal and Unterman, Avraham and Hamiel, Uri and Baris Feldman, Hagit and Marom, Daphna and Hagin, David},
  title = {Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  doi = {10.1007/s10875-026-02045-7}
}
Kostenlos starten →